Separately, Zacks Investment Research raised Rewalk Robotics from a sell rating to a hold rating in a research report on Tuesday, October 15th.
Shares of RWLK stock traded down $0.10 during trading hours on Thursday, reaching $1.99. 76,800 shares of the company’s stock were exchanged, compared to its average volume of 553,210. The stock’s 50 day moving average is $2.83 and its 200-day moving average is $3.53. The company has a market cap of $16.36 million, a price-to-earnings ratio of -0.14 and a beta of 1.56. The company has a current ratio of 2.66, a quick ratio of 3.09 and a debt-to-equity ratio of 0.30. Rewalk Robotics has a fifty-two week low of $1.94 and a fifty-two week high of $10.08.
An institutional investor recently bought a new position in Rewalk Robotics stock. Gabelli Funds LLC purchased a new position in shares of Rewalk Robotics Ltd (NASDAQ:RWLK) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 27,064 shares of the medical device company’s stock, valued at approximately $118,000. Gabelli Funds LLC owned approximately 0.60% of Rewalk Robotics at the end of the most recent quarter. Hedge funds and other institutional investors own 7.60% of the company’s stock.
About Rewalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.
Featured Story: What Are Treasury Bonds?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Rewalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rewalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.